The Synovial Membrane,Liver,and Tongue: Target Organs for a Ricin A-Chain Immunotoxin (ZD0490)

Abstract

ZD0490 is an immunotoxin consisting of a mouse monoclonal antibody conjugated to recombinant ricin A-chain (rRAC). It was developed at Zeneca Pharmaceuticals as a treatment for certain antigen-bearing tumors. During safety evaluation studies in rats, a number of reversible inflammatory changes were seen. The synovial membranes of articular joints showed a marked degeneration and necrosis with an associated inflammation. When of mild severity only the synovial membrane was involved, but when more severe many adjacent tissues including the surface of the articular cartilage were affected. Some nonspecific skeletal muscle toxicity occurred. However, tongues from the intravenously (tail) dosed rats consistently showed inflammation specifically located in the ventral subepithelial area with myocyte degeneration and necrosis. Also, hepatic peliosis primarily located in the subcapsular areas was induced. Studies with rRAC alone indicated that ricin A-chain (RAC) is the component responsible for these findings. It is suggested that cells of a macrophage type with the ability to specifically bind RAC may at least in part determine the location and nature of the changes seen.

Keywords

Ricin immunotoxin rodent synovial membrane peliosis macrophage

References

Blakey DC , Skilleter DN , Price RJ , and Thorpe PE (1988). Uptake of native and deglycosylated ricin A-chain immunotoxins by mouse liver parenchymal and non-parenchymal cells in vitro and in vivo. Biochim. Biophys. Acta 968: 172-178.

Calvete JA , Newell DR , Wright AF , and Rose MS (1994). In vitro and in vivo antitumour activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer. Cancer Res. 54: 4684-4690.

Derenzini M. , Bonnetti E. , Marinozzi V. , and Stirpe F. (1987). Toxin effect of ricin. Studies on the pathogenesis of liver lesions. Virchows Arch. B Cell Pathol. 20: 15-28.

Edwards JCW (1994). The nature and origins of synovium: Experimental approaches to the study of synoviocyte differentiation . J. Anat. 184: 493-501.

Endo Y. (1989). The mechanism of action of the cytotoxic proteins α-sarcin and ricin A-chain on eukaryotic ribosomes. Seikagaku. J. Jap. Chem. Soc. 61: 1209-1223.

Fiani ML , Blum JS , and Stahl PD (1993). Endosomal proteolysis precedes ricin A-chain toxicity in macrophages. Arch. Biochem. Biophys. 307: 225-230.

Harkonen S. , Stoudemire J. , Mischak R. , Spitler LE , Lopez H. , and Scannon P. (1987). Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin to rats. Cancer Res. 47: 1377-1382.

Kanellos J. , MacKenzie FC , and Pietersz A. (1988). In vivo studies of whole ricin monoclonal antibody immunoconjugates for the treatment of murine tumours. Immunol. Cell Biol. 66: 403-415.

Kung AHC , Cavagnaro JA , Makin A. , White MA , and Kong KN (1995). Toxicologic evaluations of an immunotoxin, H65-RTA. Fund. Appl. Tox. 26: 75-84.

10.

Mano M. , Ooi Y. , and Saito T. (1994). Ultracytochemical characteristics of two cell types in the rat knee synovial membrane. Acta. Histochem. Cytochem. 27: 57-65.

11.

Richer G. , Carriere D. , Blythman HE , and Vidal H. (1982). Histopathological changes induced in mice by the plant toxin ricin and its highly purified subunits A-chain and B-chain. In: Lectins-Bi- ology, Biochemistry, Clinical Biochemistry, Vol. II , TC Boghansen (ed). Walter de Gruyter, Berlin, pp. 3-22.

12.

Simmons B. , Stahl P. , and Russell J. (1986). Mannose-receptor mediated uptake of ricintoxin and ricin A chain by macrophages. J. Cell. Biol. 261: 7912-7920.

13.

Skilleter DN and Foxwell BMJ (1986). Selective uptake of ricin A-chain by hepatic non-parenchymal cells in vitro. FEBS Lett. 196: 344-348.

14.

Thorpe P. and Ross W. (1982). The preparation and cytotoxic properties of antibody-ricin conjugates. Immunol. Rev. 62: 119-158.

15.

Vitetta ES and Uhr JW (1985). Immunotoxins. Ann. Rev. Immunol . 3: 197-212.